Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.052 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |